Caribou Biosciences (CRBU) FCF Margin (2020 - 2026)
Caribou Biosciences' (CRBU) quarterly FCF Margin came in at 1125.74% in Q1 2026, up 47932.0% year-on-year from N/an in Q1 2025, and down 115.62% on a QoQ basis from 522.1% in Q4 2025.
Caribou Biosciences (CRBU) FCF Margin (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of FCF Margin data on file, last reported at 1125.74% in Q1 2026.
- On a quarterly basis, FCF Margin rose 47932.0% year-over-year to 1125.74% in Q1 2026; TTM through Mar 2026 was 906.61%, a 52710.0% increase from a year earlier, with the FY2025 full-year figure at 1006.82%, up 42484.0% from the prior year.
- FCF Margin for Q1 2026 stood at 1125.74%, down from 522.1% in the prior quarter.
- Over the last five years, FCF Margin for CRBU reached as high as 141.75% in Q3 2023 and fell as low as 1924.75% in Q4 2024.
- Historically, FCF Margin has averaged 965.0% across 5 years, with a median of 846.74% in 2023.
- Across the five-year window, FCF Margin sank 212007 bps in 2022 and surged 140265 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 584.24% in 2022, then dropped by 14 bps to 664.87% in 2023, then tumbled by 189 bps to 1924.75% in 2024, then surged by 73 bps to 522.1% in 2025, then plunged by 116 bps to 1125.74% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 1125.74% in Q1 2026, 522.1% in Q4 2025, and 1215.88% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - | -1,125.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,125.74% |
| Dec 31, 2025 | -522.10% |
| Sep 30, 2025 | -1,215.88% |
| Jun 30, 2025 | -1,022.98% |
| Mar 31, 2025 | -1,605.06% |
| Dec 31, 2024 | -1,924.75% |
| Sep 30, 2024 | -1,623.47% |
| Jun 30, 2024 | -912.04% |
| Mar 31, 2024 | -1,591.23% |
| Dec 31, 2023 | -664.87% |
| Sep 30, 2023 | -141.75% |
| Jun 30, 2023 | -480.83% |
| Mar 31, 2023 | -846.74% |
| Dec 31, 2022 | -584.24% |
| Sep 30, 2022 | -718.44% |
| Jun 30, 2022 | -584.28% |
| Mar 31, 2022 | -840.69% |
| Dec 31, 2021 | -908.25% |
| Sep 30, 2021 | -370.35% |
| Jun 30, 2021 | -1,149.05% |